Steroid Recognition in Adhesion GPCRs: A Structural and Pharmacological Perspective
Bethany Fleming1, Abdul-Akim Guseinov1, Irina G Tikhonova2
1Centre for Translational Pharmacology, School of Molecular Biosciences, University of Glasgow, Glasgow, UK, Scotland.
Pharmacology Research & Perspectives
|February 16, 2026
Summary
Steroids may bind to adhesion G protein-coupled receptors (GPCRs), a promising drug target class. Structural studies reveal a steroid-binding pocket in ADGRD1, suggesting a shared recognition mechanism across GPCRs.
Area of Science:
- Biochemistry
- Pharmacology
- Structural Biology
Background:
- Adhesion GPCRs represent a significant class of receptors with substantial therapeutic potential.
- While research has primarily investigated the ADGR'G' subfamily, recent structural data has expanded the scope of inquiry.
- The physiological relevance and reproducibility of steroid binding to adhesion GPCRs remain subjects of ongoing scientific discussion.
Purpose of the Study:
- To explore the broader implications of steroid-ligand interactions with adhesion GPCRs.
- To evaluate the structural evidence for steroid binding across different adhesion GPCR subfamilies.
- To assess the plausibility of a conserved steroid recognition mechanism within the adhesion GPCR superfamily.
Main Methods:
- Review of existing structural evidence for steroid-GPCR interactions.
- Analysis of cryo-electron microscopy (cryo-EM) structures of ADGRD1 bound to androgens.
- Comparative molecular docking and homology modeling studies.
Main Results:
- Cryo-EM structures identified a potential steroid-binding pocket in ADGRD1.
- These findings facilitated the rational design of a novel, selective synthetic agonist for ADGRD1.
- Structural comparisons suggest conserved features may enable a shared steroid recognition mechanism.
Conclusions:
- Steroids show potential as generalizable ligands for adhesion GPCRs.
- The discovery of a steroid-binding pocket in ADGRD1 supports a broader role for steroids in GPCR signaling.
- Further investigation is warranted to fully elucidate the physiological significance and therapeutic applications of steroid-adhesion GPCR interactions.
More Related Videos
Related Concept Videos
Transducer Mechanism: G Protein–Coupled Receptors
4.4K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
4.4K
G Protein-coupled Receptors
17.9K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
17.9K
GPCRs Regulate Adenylyl Cylase Activity
7.7K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.7K
Assembly of Signaling Complexes
6.7K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
6.7K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.9K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.9K
Adrenergic Receptors (Adrenoceptors): Classification
5.1K
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
5.1K


